Form 8-K - Current report:
SEC Accession No. 0001477932-21-002261
Filing Date
2021-04-14
Accepted
2021-04-14 08:00:20
Documents
1
Period of Report
2021-01-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nbio_8k.htm 8-K 13812
  Complete submission text file 0001477932-21-002261.txt   14994
Mailing Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121
Business Address 6330 NANCY RIDGE DR. SUITE 105 SAN DIEGO CA 92121 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 000-55299 | Film No.: 21824552
SIC: 2834 Pharmaceutical Preparations